Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuromodulation Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Internal Treatment
1.2.3 External Treatment
1.3 Market by Application
1.3.1 Global Neuromodulation Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Ischemia
1.3.3 Chronic Pain
1.3.4 Parkinson’s
1.3.5 Depression
1.3.6 Tremor
1.3.7 Epilepsy
1.3.8 Migraine
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuromodulation Market Perspective (2018-2033)
2.2 Neuromodulation Growth Trends by Region
2.2.1 Global Neuromodulation Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Neuromodulation Historic Market Size by Region (2018-2023)
2.2.3 Neuromodulation Forecasted Market Size by Region (2024-2033)
2.3 Neuromodulation Market Dynamics
2.3.1 Neuromodulation Industry Trends
2.3.2 Neuromodulation Market Drivers
2.3.3 Neuromodulation Market Challenges
2.3.4 Neuromodulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuromodulation Players by Revenue
3.1.1 Global Top Neuromodulation Players by Revenue (2018-2023)
3.1.2 Global Neuromodulation Revenue Market Share by Players (2018-2023)
3.2 Global Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuromodulation Revenue
3.4 Global Neuromodulation Market Concentration Ratio
3.4.1 Global Neuromodulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuromodulation Revenue in 2022
3.5 Neuromodulation Key Players Head office and Area Served
3.6 Key Players Neuromodulation Product Solution and Service
3.7 Date of Enter into Neuromodulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuromodulation Breakdown Data by Type
4.1 Global Neuromodulation Historic Market Size by Type (2018-2023)
4.2 Global Neuromodulation Forecasted Market Size by Type (2024-2033)
5 Neuromodulation Breakdown Data by Application
5.1 Global Neuromodulation Historic Market Size by Application (2018-2023)
5.2 Global Neuromodulation Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Neuromodulation Market Size (2018-2033)
6.2 North America Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Neuromodulation Market Size by Country (2018-2023)
6.4 North America Neuromodulation Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuromodulation Market Size (2018-2033)
7.2 Europe Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Neuromodulation Market Size by Country (2018-2023)
7.4 Europe Neuromodulation Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuromodulation Market Size (2018-2033)
8.2 Asia-Pacific Neuromodulation Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Neuromodulation Market Size by Region (2018-2023)
8.4 Asia-Pacific Neuromodulation Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuromodulation Market Size (2018-2033)
9.2 Latin America Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Neuromodulation Market Size by Country (2018-2023)
9.4 Latin America Neuromodulation Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuromodulation Market Size (2018-2033)
10.2 Middle East & Africa Neuromodulation Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Neuromodulation Market Size by Country (2018-2023)
10.4 Middle East & Africa Neuromodulation Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Neuromodulation Introduction
11.1.4 Medtronic Revenue in Neuromodulation Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific Corporation
11.2.1 Boston Scientific Corporation Company Detail
11.2.2 Boston Scientific Corporation Business Overview
11.2.3 Boston Scientific Corporation Neuromodulation Introduction
11.2.4 Boston Scientific Corporation Revenue in Neuromodulation Business (2018-2023)
11.2.5 Boston Scientific Corporation Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Neuromodulation Introduction
11.3.4 Abbott Revenue in Neuromodulation Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 LivaNova
11.4.1 LivaNova Company Detail
11.4.2 LivaNova Business Overview
11.4.3 LivaNova Neuromodulation Introduction
11.4.4 LivaNova Revenue in Neuromodulation Business (2018-2023)
11.4.5 LivaNova Recent Development
11.5 Synapse Biomedical, Inc.
11.5.1 Synapse Biomedical, Inc. Company Detail
11.5.2 Synapse Biomedical, Inc. Business Overview
11.5.3 Synapse Biomedical, Inc. Neuromodulation Introduction
11.5.4 Synapse Biomedical, Inc. Revenue in Neuromodulation Business (2018-2023)
11.5.5 Synapse Biomedical, Inc. Recent Development
11.6 Nevro Corporation
11.6.1 Nevro Corporation Company Detail
11.6.2 Nevro Corporation Business Overview
11.6.3 Nevro Corporation Neuromodulation Introduction
11.6.4 Nevro Corporation Revenue in Neuromodulation Business (2018-2023)
11.6.5 Nevro Corporation Recent Development
11.7 NeuroSigma
11.7.1 NeuroSigma Company Detail
11.7.2 NeuroSigma Business Overview
11.7.3 NeuroSigma Neuromodulation Introduction
11.7.4 NeuroSigma Revenue in Neuromodulation Business (2018-2023)
11.7.5 NeuroSigma Recent Development
11.8 NeuroPace
11.8.1 NeuroPace Company Detail
11.8.2 NeuroPace Business Overview
11.8.3 NeuroPace Neuromodulation Introduction
11.8.4 NeuroPace Revenue in Neuromodulation Business (2018-2023)
11.8.5 NeuroPace Recent Development
11.9 Neuronetics
11.9.1 Neuronetics Company Detail
11.9.2 Neuronetics Business Overview
11.9.3 Neuronetics Neuromodulation Introduction
11.9.4 Neuronetics Revenue in Neuromodulation Business (2018-2023)
11.9.5 Neuronetics Recent Development
11.10 BioControl Medical
11.10.1 BioControl Medical Company Detail
11.10.2 BioControl Medical Business Overview
11.10.3 BioControl Medical Neuromodulation Introduction
11.10.4 BioControl Medical Revenue in Neuromodulation Business (2018-2023)
11.10.5 BioControl Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Neuromodulation Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Internal Treatment
Table 3. Key Players of External Treatment
Table 4. Global Neuromodulation Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Neuromodulation Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Neuromodulation Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Neuromodulation Market Share by Region (2018-2023)
Table 8. Global Neuromodulation Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Neuromodulation Market Share by Region (2024-2033)
Table 10. Neuromodulation Market Trends
Table 11. Neuromodulation Market Drivers
Table 12. Neuromodulation Market Challenges
Table 13. Neuromodulation Market Restraints
Table 14. Global Neuromodulation Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Neuromodulation Market Share by Players (2018-2023)
Table 16. Global Top Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation as of 2022)
Table 17. Ranking of Global Top Neuromodulation Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Neuromodulation Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neuromodulation Product Solution and Service
Table 21. Date of Enter into Neuromodulation Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neuromodulation Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Neuromodulation Revenue Market Share by Type (2018-2023)
Table 25. Global Neuromodulation Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Neuromodulation Revenue Market Share by Type (2024-2033)
Table 27. Global Neuromodulation Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Neuromodulation Revenue Market Share by Application (2018-2023)
Table 29. Global Neuromodulation Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Neuromodulation Revenue Market Share by Application (2024-2033)
Table 31. North America Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Neuromodulation Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Neuromodulation Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Neuromodulation Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Neuromodulation Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Neuromodulation Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Neuromodulation Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Neuromodulation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Neuromodulation Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Neuromodulation Market Size by Country (2024-2033) & (US$ Million)
Table 46. Medtronic Company Detail
Table 47. Medtronic Business Overview
Table 48. Medtronic Neuromodulation Product
Table 49. Medtronic Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. Boston Scientific Corporation Company Detail
Table 52. Boston Scientific Corporation Business Overview
Table 53. Boston Scientific Corporation Neuromodulation Product
Table 54. Boston Scientific Corporation Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 55. Boston Scientific Corporation Recent Development
Table 56. Abbott Company Detail
Table 57. Abbott Business Overview
Table 58. Abbott Neuromodulation Product
Table 59. Abbott Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. LivaNova Company Detail
Table 62. LivaNova Business Overview
Table 63. LivaNova Neuromodulation Product
Table 64. LivaNova Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 65. LivaNova Recent Development
Table 66. Synapse Biomedical, Inc. Company Detail
Table 67. Synapse Biomedical, Inc. Business Overview
Table 68. Synapse Biomedical, Inc. Neuromodulation Product
Table 69. Synapse Biomedical, Inc. Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 70. Synapse Biomedical, Inc. Recent Development
Table 71. Nevro Corporation Company Detail
Table 72. Nevro Corporation Business Overview
Table 73. Nevro Corporation Neuromodulation Product
Table 74. Nevro Corporation Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 75. Nevro Corporation Recent Development
Table 76. NeuroSigma Company Detail
Table 77. NeuroSigma Business Overview
Table 78. NeuroSigma Neuromodulation Product
Table 79. NeuroSigma Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 80. NeuroSigma Recent Development
Table 81. NeuroPace Company Detail
Table 82. NeuroPace Business Overview
Table 83. NeuroPace Neuromodulation Product
Table 84. NeuroPace Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 85. NeuroPace Recent Development
Table 86. Neuronetics Company Detail
Table 87. Neuronetics Business Overview
Table 88. Neuronetics Neuromodulation Product
Table 89. Neuronetics Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 90. Neuronetics Recent Development
Table 91. BioControl Medical Company Detail
Table 92. BioControl Medical Business Overview
Table 93. BioControl Medical Neuromodulation Product
Table 94. BioControl Medical Revenue in Neuromodulation Business (2018-2023) & (US$ Million)
Table 95. BioControl Medical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuromodulation Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Neuromodulation Market Share by Type: 2022 VS 2033
Figure 3. Internal Treatment Features
Figure 4. External Treatment Features
Figure 5. Global Neuromodulation Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Neuromodulation Market Share by Application: 2022 VS 2033
Figure 7. Ischemia Case Studies
Figure 8. Chronic Pain Case Studies
Figure 9. Parkinson’s Case Studies
Figure 10. Depression Case Studies
Figure 11. Tremor Case Studies
Figure 12. Epilepsy Case Studies
Figure 13. Migraine Case Studies
Figure 14. Neuromodulation Report Years Considered
Figure 15. Global Neuromodulation Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Neuromodulation Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Neuromodulation Market Share by Region: 2022 VS 2033
Figure 18. Global Neuromodulation Market Share by Players in 2022
Figure 19. Global Top Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuromodulation as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Neuromodulation Revenue in 2022
Figure 21. North America Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Neuromodulation Market Share by Country (2018-2033)
Figure 23. United States Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Neuromodulation Market Share by Country (2018-2033)
Figure 27. Germany Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Neuromodulation Market Share by Region (2018-2033)
Figure 35. China Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Neuromodulation Market Share by Country (2018-2033)
Figure 43. Mexico Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Neuromodulation Market Share by Country (2018-2033)
Figure 47. Turkey Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Neuromodulation Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Medtronic Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 50. Boston Scientific Corporation Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 51. Abbott Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 52. LivaNova Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 53. Synapse Biomedical, Inc. Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 54. Nevro Corporation Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 55. NeuroSigma Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 56. NeuroPace Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 57. Neuronetics Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 58. BioControl Medical Revenue Growth Rate in Neuromodulation Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed